Barbara Jacquelyn Sahakian
-
Professor of Clinical Neuropsychology,
University of Cambridge
Professor Barbara J Sahakian is based at the University of Cambridge Department of Psychiatry and Behavioural and Clinical Neuroscience Institute. Sahakian is also an Honorary Clinical Psychologist at Addenbrooke's Hospital and a Fellow of Clare Hall, Cambridge. She is a Fellow of the British Academy and the Academy of Medical Sciences. She was a Member of the International Expert Jury for the 2017 Else Kröner-Fresenius-Stiftung Prize. She is a Past President of the British Association for Psychopharmacology and of the International Neuroethics Society. In 2024 she was awarded a CBE for Services to Research in Human Cognitive Processes.
Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. She is best known for her work on problems of cognition and motivation in brain injury, 'hot' and 'cold' cognitive deficits in depression and early detection and early treatment with cholinesterase inhibitors in Alzheimer's disease. She has over 600 publications in high impact scientific journals. Google Scholar credits her with an h-index of 143. Sahakian co-invented the neuropsychological CANTAB and EMOTICOM tests () and the University of Cambridge/PEAK Advanced Training Programme and the Wizard Apprentice Memory Game () .
Sahakian has contributed to Neuroscience and Mental Health Policy, including the UK Government Foresight Project on Mental Capital and Wellbeing (Beddington et al., 2008, Nature), the Strategy for Mental Health for the Medical Research Council (Sahakian et al., 2010, The Lancet) and the Grand Challenges in Global Mental Health (Collins et al., 2011, Nature). She was a member of the Institute of Medicine Planning Committee (USA) on Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression. She is on the Committee for the Strategy for Neuroscience and Mental Health for the Department of Health. In March 2017, she participated in the Global Council on Brain Health meeting in Washington, DC. She has spoken at the World Economic Forum, Davos, 2014 and is a member of the WEF on the Future of Neurotechnologies and Brain Science. She is also on the Clinical Advisory Board of the Human Brain Project. She is a member of the Wellcome Trust Science Innovation Translation Programme Advisory Group and the Wellcome's Innovator Awards Advisory Group. She is a member of the Irish Research Council Laureate Awards Committee.
She has also co-authored a number of popular science books including Bad Moves: How decision-making goes wrong and the ethics of smart drugs (2013), Sex, Lies and Brain Scans: How fMRI reveals what really goes on in our minds (2017) and Brain Boost: Healthy habits for a happier life (2025).
Experience-
–present
Professor of Clinical Neuropsychology, University of Cambridge
Fellow of the British Academy; Fellow of the Academy of Medical Sciences; Fellow of Clare Hall


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Pascal And Treehouse Partner On Proof Of Concept To Pioneer Smart Clearing For Decentralized Fixed Income Products
- Ecosync & Carboncore Launch Full Stages Refi Infrastructure Linking Carbon Credits With Web3
- Japan Well Intervention Market Size To Reach USD 776.0 Million By 2033 CAGR Of 4.50%
- Nickel Market Estimated To Exceed USD 55.5 Billion By 2033
- United States In Vitro Diagnostics Market Trends With Growth Forecast Outlook 20252033
- Primexbt Launches Empowering Traders To Succeed Campaign, Leading A New Era Of Trading
Comments
No comment